Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
ConditionPrimary Aldosteronism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorQifu Li
About this trial
1. Aim to investigate the pathological feature of UPA in Asians 2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians. 3. To explore a new pathological type of unilateral primary aldosterone
Eligibility criteria
Qualifiers
No gender limitation;
Age 18-80 years old;
The patient was diagnosed with UPA and underwent total adrenal resection.
Disqualifiers
Bilateral disease
Partial of no biochemical response in follow-up
partial adrenalectomy
Trial design
Treatments tested in this trial
- Tissue specimens were stained by histopathology of hematoxylin-eosin
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Qifu Li
Lead sponsor
Chongqing Medical University
Sponsor institution
Source ClinicalTrials.gov